Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Prabhakar

Showing results (541-550 of 554) with videos related to

Pageof 56
Sort By:
Journal of Medicinal Chemistry|June 5, 2007
C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR studyMohammad Saquib, Manish K Gupta, Ram Sagar, et al.
Science Advances|October 8, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastasesBridget P Keenan, Guilin Qiao, Nicholas Kunda, et al.
Contemporary Clinical Trials Communications|July 20, 2018
Implementing a STEMI system of care in urban Bangalore: Rationale and Study Design for heart rescue IndiaAruna Ramesh, Kenneth A LaBresh, Rhea Begeman, et al.
Journal of Medicinal Chemistry|August 4, 2009
Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like proteaseArun K Ghosh, Jun Takayama, Yoann Aubin, et al.
Cell|October 7, 2014
Coreceptor scanning by the T cell receptor provides a mechanism for T cell toleranceOndrej Stepanek, Arvind S Prabhakar, Celine Osswald, et al.
Human Gene Therapy|May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 TherapyYuefeng Yang, Weidong Xu, Di Peng, et al.
Leukemia|September 12, 2013
Regulation of MEIS1 by distal enhancer elements in acute leukemiaQ F Wang, Y J Li, J F Dong, et al.
American Journal of Respiratory Cell and Molecular Biology|June 21, 2011
Type 2 deiodinase and host responses of sepsis and acute lung injuryShwu-Fan Ma, Lishi Xie, Maria Pino-Yanes, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsMarcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe, et al.
Frontiers in Medicine|November 1, 2023
Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infectionChen Chen, Sairam Parthasarathy, Jacqueline M Leung, et al.
Pageof 56

Showing results (541-550 of 554) with videos related to

Sort By:
Pageof 56
Journal of Medicinal Chemistry|June 5, 2007
C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR studyMohammad Saquib, Manish K Gupta, Ram Sagar, et al.
Science Advances|October 8, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastasesBridget P Keenan, Guilin Qiao, Nicholas Kunda, et al.
Contemporary Clinical Trials Communications|July 20, 2018
Implementing a STEMI system of care in urban Bangalore: Rationale and Study Design for heart rescue IndiaAruna Ramesh, Kenneth A LaBresh, Rhea Begeman, et al.
Journal of Medicinal Chemistry|August 4, 2009
Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like proteaseArun K Ghosh, Jun Takayama, Yoann Aubin, et al.
Cell|October 7, 2014
Coreceptor scanning by the T cell receptor provides a mechanism for T cell toleranceOndrej Stepanek, Arvind S Prabhakar, Celine Osswald, et al.
Human Gene Therapy|May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 TherapyYuefeng Yang, Weidong Xu, Di Peng, et al.
Leukemia|September 12, 2013
Regulation of MEIS1 by distal enhancer elements in acute leukemiaQ F Wang, Y J Li, J F Dong, et al.
American Journal of Respiratory Cell and Molecular Biology|June 21, 2011
Type 2 deiodinase and host responses of sepsis and acute lung injuryShwu-Fan Ma, Lishi Xie, Maria Pino-Yanes, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsMarcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe, et al.
Frontiers in Medicine|November 1, 2023
Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infectionChen Chen, Sairam Parthasarathy, Jacqueline M Leung, et al.
Pageof 56